vs

Side-by-side financial comparison of InterDigital, Inc. (IDCC) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

InterDigital, Inc. is the larger business by last-quarter revenue ($205.4M vs $142.0M, roughly 1.4× Oncology Institute, Inc.). InterDigital, Inc. runs the higher net margin — 36.7% vs -5.3%, a 41.9% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs -2.4%). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs -4.1%).

InterDigital, Inc. is an American technology research and development company that provides wireless and video technologies for mobile devices, networks, and services worldwide. Founded in 1972, InterDigital is listed on the Nasdaq and is included in the S&P 600 index.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

IDCC vs TOI — Head-to-Head

Bigger by revenue
IDCC
IDCC
1.4× larger
IDCC
$205.4M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+44.0% gap
TOI
41.6%
-2.4%
IDCC
Higher net margin
IDCC
IDCC
41.9% more per $
IDCC
36.7%
-5.3%
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
-4.1%
IDCC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
IDCC
IDCC
TOI
TOI
Revenue
$205.4M
$142.0M
Net Profit
$75.3M
$-7.5M
Gross Margin
Operating Margin
40.0%
-4.9%
Net Margin
36.7%
-5.3%
Revenue YoY
-2.4%
41.6%
Net Profit YoY
-34.8%
43.0%
EPS (diluted)
$2.14
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IDCC
IDCC
TOI
TOI
Q1 26
$205.4M
Q4 25
$158.2M
$142.0M
Q3 25
$164.7M
$136.6M
Q2 25
$300.6M
$119.8M
Q1 25
$210.5M
$104.4M
Q4 24
$252.8M
$100.3M
Q3 24
$128.7M
$99.9M
Q2 24
$223.5M
$98.6M
Net Profit
IDCC
IDCC
TOI
TOI
Q1 26
$75.3M
Q4 25
$43.0M
$-7.5M
Q3 25
$67.5M
$-16.5M
Q2 25
$180.6M
$-17.0M
Q1 25
$115.6M
$-19.6M
Q4 24
$133.1M
$-13.2M
Q3 24
$34.2M
$-16.1M
Q2 24
$109.7M
$-15.5M
Operating Margin
IDCC
IDCC
TOI
TOI
Q1 26
40.0%
Q4 25
30.2%
-4.9%
Q3 25
46.0%
-5.9%
Q2 25
68.3%
-9.4%
Q1 25
62.6%
-9.5%
Q4 24
64.3%
-11.9%
Q3 24
30.6%
-13.9%
Q2 24
59.9%
-16.6%
Net Margin
IDCC
IDCC
TOI
TOI
Q1 26
36.7%
Q4 25
27.2%
-5.3%
Q3 25
41.0%
-12.1%
Q2 25
60.1%
-14.2%
Q1 25
54.9%
-18.8%
Q4 24
52.7%
-13.1%
Q3 24
26.6%
-16.1%
Q2 24
49.1%
-15.7%
EPS (diluted)
IDCC
IDCC
TOI
TOI
Q1 26
$2.14
Q4 25
$1.07
$-0.04
Q3 25
$1.93
$-0.14
Q2 25
$5.35
$-0.15
Q1 25
$3.45
$-0.21
Q4 24
$4.12
$-0.14
Q3 24
$1.14
$-0.18
Q2 24
$3.93
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IDCC
IDCC
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$377.8M
Stockholders' EquityBook value
$1.1B
$-15.7M
Total Assets
$2.1B
$164.7M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IDCC
IDCC
TOI
TOI
Q1 26
Q4 25
$1.2B
Q3 25
$1.3B
Q2 25
$937.0M
Q1 25
$883.3M
Q4 24
$958.2M
Q3 24
$813.2M
Q2 24
$760.3M
$9.9M
Total Debt
IDCC
IDCC
TOI
TOI
Q1 26
$377.8M
Q4 25
$16.3M
Q3 25
$17.1M
Q2 25
$16.6M
Q1 25
$16.0M
Q4 24
$15.4M
Q3 24
$18.3M
Q2 24
$17.7M
Stockholders' Equity
IDCC
IDCC
TOI
TOI
Q1 26
$1.1B
Q4 25
$1.1B
$-15.7M
Q3 25
$1.1B
$-12.3M
Q2 25
$1.1B
$-9.0M
Q1 25
$936.9M
$5.1M
Q4 24
$857.2M
$3.6M
Q3 24
$722.5M
$15.5M
Q2 24
$696.8M
$29.2M
Total Assets
IDCC
IDCC
TOI
TOI
Q1 26
$2.1B
Q4 25
$2.1B
$164.7M
Q3 25
$2.1B
$163.6M
Q2 25
$2.0B
$159.8M
Q1 25
$1.9B
$164.0M
Q4 24
$1.8B
$172.7M
Q3 24
$1.7B
$179.2M
Q2 24
$1.6B
$179.6M
Debt / Equity
IDCC
IDCC
TOI
TOI
Q1 26
0.34×
Q4 25
0.01×
Q3 25
0.02×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.03×
Q2 24
0.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IDCC
IDCC
TOI
TOI
Operating Cash FlowLast quarter
$3.2M
Free Cash FlowOCF − Capex
$2.2M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IDCC
IDCC
TOI
TOI
Q1 26
Q4 25
$544.5M
$3.2M
Q3 25
$395.9M
$-12.6M
Q2 25
$105.1M
$-10.2M
Q1 25
$-20.0M
$-5.0M
Q4 24
$271.5M
$4.2M
Q3 24
$77.6M
$819.0K
Q2 24
$-48.9M
$-15.7M
Free Cash Flow
IDCC
IDCC
TOI
TOI
Q1 26
Q4 25
$528.6M
$2.2M
Q3 25
$395.3M
$-13.2M
Q2 25
$104.5M
$-11.4M
Q1 25
$-34.5M
$-5.3M
Q4 24
$265.7M
$2.4M
Q3 24
$76.7M
$417.0K
Q2 24
$-49.5M
$-17.5M
FCF Margin
IDCC
IDCC
TOI
TOI
Q1 26
Q4 25
334.0%
1.5%
Q3 25
240.1%
-9.7%
Q2 25
34.8%
-9.5%
Q1 25
-16.4%
-5.1%
Q4 24
105.1%
2.4%
Q3 24
59.6%
0.4%
Q2 24
-22.1%
-17.7%
Capex Intensity
IDCC
IDCC
TOI
TOI
Q1 26
Q4 25
10.0%
0.7%
Q3 25
0.4%
0.4%
Q2 25
0.2%
1.0%
Q1 25
6.9%
0.3%
Q4 24
2.3%
1.8%
Q3 24
0.7%
0.4%
Q2 24
0.3%
1.9%
Cash Conversion
IDCC
IDCC
TOI
TOI
Q1 26
Q4 25
12.67×
Q3 25
5.87×
Q2 25
0.58×
Q1 25
-0.17×
Q4 24
2.04×
Q3 24
2.27×
Q2 24
-0.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IDCC
IDCC

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons